The Lung Institute: A First-of-its-Kind COPD Treatment Center Offering Cellular Therapy

COPD treatment centerThe Lung Institute is a COPD treatment center that offers hope to adults with all types of chronic obstructive pulmonary disease. Through cellular therapy, our skilled physicians can help certain patients improve their breathing, reduce lung scarring and slow the progression of conditions like emphysema, chronic bronchitis and pulmonary fibrosis.

The Lung Institute is the world’s first and only cellular therapy center to focus exclusively on COPD and interstitial lung diseases. More than 80 percent of our patients experience life-enhancing results from cellular therapy, an innovative therapy that uses a patient’s own cells – not potent drugs or invasive surgery – to promote healing in the lungs. While COPD is not reversible, cellular therapy has the potential to significantly improve quality of life. The procedure is relatively painless and performed on an outpatient basis over the course of two days, so patients are able to return to their daily routines shortly after treatment.

Coping with the effects of COPD can be a daily struggle. At the Lung Institute, we understand this, which is why we strive to make our patients’ treatment experience as comfortable and pleasant as possible. Our COPD treatment center is bright and airy, our office staff is friendly and knowledgeable and our physicians are committed to helping patients breathe easier and make informed decisions about their pulmonary health.

Since 2013, the Lug Institute has helped more than 4,000 patients manage their COPD symptoms and get back to enjoying the things they love most about life — whether that’s taking morning walks, attending sporting events or simply spending quality time with loved ones. Consider contacting our COPD treatment center at (800) 729-3065 if you’re interested in learning more about how cellular therapy may benefit you.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.